Ivermectin Solution Bioequivalence Study - With Food (Repeat)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the pharmacokinetic and bioavailability profile
(rate and amount of absorption into the bloodstream) of a test formulation of Ivermectin
solution 1 mg/ml with a marketed reference formulation of Ivermectin 3 mg tablets when taken
after a standard meal. The study is designed in accordance with the EU Note for Guidance on
the Investigation of Bioavailability and Bioequivalence 2001.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Consumer and Personal Products Worldwide